Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Urine Antigen Detection as an Aid to Diagnose Invasive Aspergillosis.

Marr KA, Datta K, Mehta S, Ostrander DB, Rock M, Francis J, Feldmesser M.

Clin Infect Dis. 2018 Nov 13;67(11):1705-1711. doi: 10.1093/cid/ciy326.

2.

Fungal disease following contaminated steroid injections: Exserohilum is ready for its close-up.

Feldmesser M.

Am J Pathol. 2013 Sep;183(3):661-4. doi: 10.1016/j.ajpath.2013.06.010. Epub 2013 Jul 19.

3.

Detection of urinary excreted fungal galactomannan-like antigens for diagnosis of invasive aspergillosis.

Dufresne SF, Datta K, Li X, Dadachova E, Staab JF, Patterson TF, Feldmesser M, Marr KA.

PLoS One. 2012;7(8):e42736. doi: 10.1371/journal.pone.0042736. Epub 2012 Aug 10.

4.

Mouse models for the study of fungal pneumonia: a collection of detailed experimental protocols for the study of Coccidioides, Cryptococcus, Fusarium, Histoplasma and combined infection due to Aspergillus-Rhizopus.

Muhammed M, Feldmesser M, Shubitz LF, Lionakis MS, Sil A, Wang Y, Glavis-Bloom J, Lewis RE, Galgiani JN, Casadevall A, Kontoyiannis DP, Mylonakis E.

Virulence. 2012 May 1;3(3):329-38. doi: 10.4161/viru.20142. Epub 2012 May 1.

5.

Multicenter, prospective clinical evaluation of respiratory samples from subjects at risk for Pneumocystis jirovecii infection by use of a commercial real-time PCR assay.

Hauser PM, Bille J, Lass-Flörl C, Geltner C, Feldmesser M, Levi M, Patel H, Muggia V, Alexander B, Hughes M, Follett SA, Cui X, Leung F, Morgan G, Moody A, Perlin DS, Denning DW.

J Clin Microbiol. 2011 May;49(5):1872-8. doi: 10.1128/JCM.02390-10. Epub 2011 Mar 2.

6.

A role for the unfolded protein response (UPR) in virulence and antifungal susceptibility in Aspergillus fumigatus.

Richie DL, Hartl L, Aimanianda V, Winters MS, Fuller KK, Miley MD, White S, McCarthy JW, Latgé JP, Feldmesser M, Rhodes JC, Askew DS.

PLoS Pathog. 2009 Jan;5(1):e1000258. doi: 10.1371/journal.ppat.1000258. Epub 2009 Jan 9.

7.

Adoptive transfer of HER2/neu-specific T cells expanded with alternating gamma chain cytokines mediate tumor regression when combined with the depletion of myeloid-derived suppressor cells.

Morales JK, Kmieciak M, Graham L, Feldmesser M, Bear HD, Manjili MH.

Cancer Immunol Immunother. 2009 Jun;58(6):941-53. doi: 10.1007/s00262-008-0609-z. Epub 2008 Nov 1.

8.

Caspofungin modulates inflammatory responses to Aspergillus fumigatus through stage-specific effects on fungal beta-glucan exposure.

Hohl TM, Feldmesser M, Perlin DS, Pamer EG.

J Infect Dis. 2008 Jul 15;198(2):176-85. doi: 10.1086/589304.

9.

Unexpected link between metal ion deficiency and autophagy in Aspergillus fumigatus.

Richie DL, Fuller KK, Fortwendel J, Miley MD, McCarthy JW, Feldmesser M, Rhodes JC, Askew DS.

Eukaryot Cell. 2007 Dec;6(12):2437-47. Epub 2007 Oct 5.

10.

Aspergillus fumigatus: principles of pathogenesis and host defense.

Hohl TM, Feldmesser M.

Eukaryot Cell. 2007 Nov;6(11):1953-63. Epub 2007 Sep 21. Review. No abstract available.

11.

Development of candidemia on caspofungin therapy: a case report.

Cheung C, Guo Y, Gialanella P, Feldmesser M.

Infection. 2006 Dec;34(6):345-8.

PMID:
17180591
12.

Vesicular polysaccharide export in Cryptococcus neoformans is a eukaryotic solution to the problem of fungal trans-cell wall transport.

Rodrigues ML, Nimrichter L, Oliveira DL, Frases S, Miranda K, Zaragoza O, Alvarez M, Nakouzi A, Feldmesser M, Casadevall A.

Eukaryot Cell. 2007 Jan;6(1):48-59. Epub 2006 Nov 17.

13.

Role of neutrophils in invasive aspergillosis.

Feldmesser M.

Infect Immun. 2006 Dec;74(12):6514-6. Epub 2006 Oct 9. No abstract available.

14.

Prospects of vaccines for invasive aspergillosis.

Feldmesser M.

Med Mycol. 2005 Nov;43(7):571-87. Review.

PMID:
16396243
15.

Aspergillus fumigatus triggers inflammatory responses by stage-specific beta-glucan display.

Hohl TM, Van Epps HL, Rivera A, Morgan LA, Chen PL, Feldmesser M, Pamer EG.

PLoS Pathog. 2005 Nov;1(3):e30. Epub 2005 Nov 18.

16.

Laccase expression in murine pulmonary Cryptococcus neoformans infection.

Garcia-Rivera J, Tucker SC, Feldmesser M, Williamson PR, Casadevall A.

Infect Immun. 2005 May;73(5):3124-7.

17.

The pathogenesis of fatal outcome in murine pulmonary aspergillosis depends on the neutrophil depletion strategy.

Stephens-Romero SD, Mednick AJ, Feldmesser M.

Infect Immun. 2005 Jan;73(1):114-25.

18.

New and emerging antifungal agents: impact on respiratory infections.

Feldmesser M.

Am J Respir Med. 2003;2(5):371-83. Review.

PMID:
14719990
19.

Neutropenia alters lung cytokine production in mice and reduces their susceptibility to pulmonary cryptococcosis.

Mednick AJ, Feldmesser M, Rivera J, Casadevall A.

Eur J Immunol. 2003 Jun;33(6):1744-53.

20.

Voriconazole inhibits fungal growth without impairing antigen presentation or T-cell activation.

Van Epps HL, Feldmesser M, Pamer EG.

Antimicrob Agents Chemother. 2003 Jun;47(6):1818-23.

21.

Induced humoral immunity and vaccination against major human fungal pathogens.

Casadevall A, Feldmesser M, Pirofski LA.

Curr Opin Microbiol. 2002 Aug;5(4):386-91. Review.

PMID:
12160857
22.

Immunoglobulin G monoclonal antibodies to Cryptococcus neoformans protect mice deficient in complement component C3.

Shapiro S, Beenhouwer DO, Feldmesser M, Taborda C, Carroll MC, Casadevall A, Scharff MD.

Infect Immun. 2002 May;70(5):2598-604.

24.

Lactobacillus endocarditis: a case report of outpatient management.

Feldmesser M, Gordon GM, Robbins N.

Heart Dis. 1999 Sep-Oct;1(4):208-9.

PMID:
11720626
25.

Both Th1 and Th2 cytokines affect the ability of monoclonal antibodies to protect mice against Cryptococcus neoformans.

Beenhouwer DO, Shapiro S, Feldmesser M, Casadevall A, Scharff MD.

Infect Immun. 2001 Oct;69(10):6445-55.

26.

Dynamic changes in the morphology of Cryptococcus neoformans during murine pulmonary infection.

Feldmesser M, Kress Y, Casadevall A.

Microbiology. 2001 Aug;147(Pt 8):2355-65.

PMID:
11496012
27.

Intracellular parasitism of macrophages by Cryptococcus neoformans.

Feldmesser M, Tucker S, Casadevall A.

Trends Microbiol. 2001 Jun;9(6):273-8. Review.

PMID:
11390242
28.
29.

The effect of the echinocandin analogue caspofungin on cell wall glucan synthesis by Cryptococcus neoformans.

Feldmesser M, Kress Y, Mednick A, Casadevall A.

J Infect Dis. 2000 Dec;182(6):1791-5. Epub 2000 Nov 8.

PMID:
11069257
30.

Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection.

Feldmesser M, Kress Y, Novikoff P, Casadevall A.

Infect Immun. 2000 Jul;68(7):4225-37.

31.

Antibody interactions with the capsule of Cryptococcus neoformans.

Feldmesser M, Rivera J, Kress Y, Kozel TR, Casadevall A.

Infect Immun. 2000 Jun;68(6):3642-50.

32.

Synthesis of polymerized melanin by Cryptococcus neoformans in infected rodents.

Rosas AL, Nosanchuk JD, Feldmesser M, Cox GM, McDade HC, Casadevall A.

Infect Immun. 2000 May;68(5):2845-53.

33.

Melanization of Cryptococcus neoformans in murine infection.

Nosanchuk JD, Valadon P, Feldmesser M, Casadevall A.

Mol Cell Biol. 1999 Jan;19(1):745-50.

34.

Organ-dependent variation of capsule thickness in Cryptococcus neoformans during experimental murine infection.

Rivera J, Feldmesser M, Cammer M, Casadevall A.

Infect Immun. 1998 Oct;66(10):5027-30.

35.

Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies.

Casadevall A, Cleare W, Feldmesser M, Glatman-Freedman A, Goldman DL, Kozel TR, Lendvai N, Mukherjee J, Pirofski LA, Rivera J, Rosas AL, Scharff MD, Valadon P, Westin K, Zhong Z.

Antimicrob Agents Chemother. 1998 Jun;42(6):1437-46.

36.
37.

Molecular characterization of a cDNA that encodes six isoforms of a novel murine A kinase anchor protein.

Dong F, Feldmesser M, Casadevall A, Rubin CS.

J Biol Chem. 1998 Mar 13;273(11):6533-41.

38.

Mechanism of action of antibody to capsular polysaccharide in Cryptococcus neoformans infection.

Feldmesser M, Casadevall A.

Front Biosci. 1998 Feb 1;3:d136-51. Review.

PMID:
9445465
39.

A controlled trial of double versus triple therapy for HIV.

Feldmesser M, Falkenberg J.

N Engl J Med. 1998 Jan 15;338(3):196; author reply 197. No abstract available.

PMID:
9441224
40.

Eosinophil-Cryptococcus neoformans interactions in vivo and in vitro.

Feldmesser M, Casadevall A, Kress Y, Spira G, Orlofsky A.

Infect Immun. 1997 May;65(5):1899-907.

41.

Effect of serum IgG1 to Cryptococcus neoformans glucuronoxylomannan on murine pulmonary infection.

Feldmesser M, Casadevall A.

J Immunol. 1997 Jan 15;158(2):790-9.

PMID:
8992996
42.

Serum cryptococcal antigen in patients with AIDS.

Feldmesser M, Harris C, Reichberg S, Khan S, Casadevall A.

Clin Infect Dis. 1996 Oct;23(4):827-30. No abstract available.

PMID:
8909854
43.

J774 murine macrophage-like cell interactions with Cryptococcus neoformans in the presence and absence of opsonins.

Mukherjee S, Feldmesser M, Casadevall A.

J Infect Dis. 1996 May;173(5):1222-31.

PMID:
8627076
44.
45.

Monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan enhance fluconazole efficacy.

Mukherjee J, Feldmesser M, Scharff MD, Casadevall A.

Antimicrob Agents Chemother. 1995 Jul;39(7):1398-405.

46.

The role of stimulus intensity and stress in opioid-mediated analgesia.

Levine JD, Feldmesser M, Tecott L, Lane S, Gordon NC.

Brain Res. 1984 Jun 25;304(2):265-9.

PMID:
6744043
47.

Pain-induced vocalization in the rat and its modification by pharmacological agents.

Levine JD, Feldmesser M, Tecott L, Gordon NC, Izdebski K.

Brain Res. 1984 Mar 26;296(1):121-7.

PMID:
6713204

Supplemental Content

Loading ...
Support Center